Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

2020; Massachusetts Medical Society; Volume: 382; Issue: 4 Linguagem: Inglês

10.1056/nejmoa1901229

ISSN

1533-4406

Autores

Shamez Ladhani, Nick Andrews, Sydel R. Parikh, Helen Campbell, Joanne White, Michael Edelstein, Xilian Bai, Jay Lucidarme, Ray Borrow, Mary Ramsay,

Tópico(s)

Vaccine Coverage and Hesitancy

Resumo

In September 2015, the United Kingdom introduced the multicomponent meningococcal group B vaccine (4CMenB, Bexsero) into its publicly funded national immunization program at a reduced two-dose priming schedule for infants, with a 12-month booster.

Referência(s)